DHR vs TSLA: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Tesla, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
VS
Tesla, Inc. · Consumer Cyclical
$400.49
-1.1% upside to fair value
Grade D
QuantHub Verdict
DHR has more upside to fair value
(+7.9%).
DHR trades at a lower forward P/E
(37.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
TSLA |
| Current Price |
$195.98 |
$400.49 |
| Fair Value Estimate |
$211.54 |
$396.15 |
| Upside to Fair Value |
+7.9%
|
-1.1%
|
| Market Cap |
$138.7B |
$1,504.1B |
| Forward P/E |
37.8x
|
334.1x
|
| EV / EBITDA |
22.8x
|
124.0x
|
| Price / Sales |
5.6x
|
15.4x
|
| Price / FCF |
26.2x
|
214.9x
|
| Revenue Growth YoY |
+3.7%
|
+15.8%
|
| Gross Margin |
60.7%
|
19.1%
|
| Operating Margin |
21.0%
|
5.0%
|
| Return on Equity |
7.1%
|
4.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.81%
|
0.47%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Tesla, Inc. is a leading global electric vehicle manufacturer and energy solutions provider, led by CEO Elon Musk since 2008. The company maintains a strong position in the EV market with a unique fast-charging and software ecosystem, although its EV market share is declining amid intensifying competition. Tesla's business quality is medium due to its narrowing moat and modest profitability, with…
Accumulation Zones
| Metric |
DHR |
TSLA |
| Zone Low |
$158.66 |
$297.11 |
| Zone High |
$179.81 |
$336.73 |
| In Buy Zone? |
No
|
No
|